Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Hannah R Hodges

1PUBLICATIONS

7CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 28, 2020

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies.

Sruthy Varghese, Snigdha Pramanik, Leila J Williams

Pageof 1

Frequent Collaborators

1 joint publications

Sruthy Varghese

1 joint publications

Leila J Williams

1 joint publications

Courtney W Hudgens

1 joint publications

Philip L Lorenzi

1 joint publications

Jennifer L McQuade

1 joint publications

Jason Roszik

1 joint publications

Weiyi Peng

Frequent Collaborators

1 joint publications

Sruthy Varghese

1 joint publications

Leila J Williams

1 joint publications

Courtney W Hudgens

1 joint publications

Philip L Lorenzi

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos